Global Biotechnology Market
Biotechnology has become the foundation on which the pharmaceutical industry and many others are progressing on. The biotech revolution has surpassed the IT revolution as well and has become the... |
Biomarkers - Advanced Technologies and Global Market
2009 - 2014
The Global Biomarker Market report analyzes the biomarker tools and services market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the global biomarker... |
Microarrays and Lab-on-a-Chip
Global Biochip Markets
Introduction
Study Goals and Objectives
BCC's Goal for This Study Was to Determine The Status of Current and Emerging Biochip Technologies and Products, and Assess Their Worldwide Growth Potential over A... |
Biotechnologies for Medical Applications
Global Markets
This Report Contains
An overview of biotechnologies used in medical applications, including amino acids, monoclonals, stem cells, botanicals, vaccines, recombinant DNA, and nanobiotechnology
Analysis of market trends, with data for 2009, estimates... |
Microarray Markets
A microarray is an arrangement of miniaturized test sites or ""spots"" on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological molecules-usually DNA... |
Genomics, Proteomics and Metabolomics in Diagnostics
Market landscape, innovative technologies and future outlook
The key factor in the current scenario for next-generation omics-based diagnostic technologies is the level of accuracy in the results, followed by the capacity to detect early, and cost. Cost... |
Biologic Imaging Reagents: Technologies and Global Markets
This report:
Describes various imaging reagent types including optical probes and dyes, imaging nanomaterials, supermolecules, contrast agents and radiopharmaceuticals
Provides market forecasts to determine the global market and future demand growth for... |
Protein Microarrays: Technology Adoption & Utilization
Technology Adoption & Utilization
Note: Please be aware that the PDF price includes a Enterprise-Wide Electronic License and one print copy.
As protein arrays have become more consistent and reliable, scientists have begun to incorporate... |
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
Report overview
The success of protein and peptide therapeutics is revolutionizing the biotech and pharmaceutical market, spurring the creation of next-generation products with reduced immunogenicity, improved safety and greater effectiveness. New... |
Analytical Chip Technology: U.S. Markets for Lab on a Chip, DNA/Gene, Protein, and other Microarrays
3rd. Edition
Analytical microchips can be considered one of the fastest growing technology segments in life sciences. The range of applications to which these miniature laboratories may be directed is very... |
Innovations in Combating Infectious Diseases
Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation
Infectious disease is not merely a problem of the past; despite significant breakthroughs achieved during the last century in the development of antibiotic, antiviral, and antiparasitic drugs and vaccines, the... |
Advances in the Use of Biomarkers in Biochip and Microarray Testing
Innovative technologies, growth opportunities and the future market outlook
Microarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a decade it is only... |
Indian Biotechnology
The global biotechnology industry in 2006 stood at USD73.12 billion up by 15.49% compared to 2005, the industry fared well in terms of fund raising, increased number of alliances and... |
Multiplex Assays in Translational Medicine
Technologies, Applications, and Future Directions
The development and growth of assay technologies has pushed translational medicine into a category unto itself. In a broad perspective on this field, this new report:
Defines translational medicine by giving... |
Development and Commercialisation of Protein Therapeutics
Technologies, pipelines and forecasts
With a combined annual market valued at $33 billion annually, the market for protein therapeutics encompasses several major drug classes and disease indications ranging from infectious disease, cancer indications, inflammatory... |
Companion Biomarkers in Drug Development
The term ""companion biomarker"" means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disease have long... |
Cancer Antibodies
Competitive Positioning for Success
This report aims to analyze the current and future potential of cancer antibodies by examining key fundamentals across the entire pipeline of antibody drug candidates. BioSeeker has identified three fundamental... |
Protein Drugs
This report analyzes the Global market for Protein Drugs in US$ Million by the following Drug Classes - Antibodies, Blood Products, Cytokines, Peptide Hormones, Vaccines, and Others (Including Peptide Antibiotics... |
Cell-Based Diagnostics: Technology, Applications, and Markets
2nd Edition
Cell analysis is not a new laboratory procedure. Clinical diagnostics using cells and tissues is one of the oldest disciplines in laboratory medicine. Histological study of biopsy samples,... |
Next-Generation Cancer Diagnostics
Technologies and Global Markets
REPORT HIGHLIGHTS
The total global annual market for next generation cancer diagnostics was $776 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach... |
Cancer Profiling and Pathways
Technologies and Global Markets
This report reviews the global markets for cancer profiling and biomarker studies and forecasts trends for use of technologies through 2015. Important cancer profiling techniques, market share by type of... |
Life Science Tools and Reagents
Global Markets
REPORT HIGHLIGHTS
The life science tools market has shown steady growth over the last couple of years despite the economic downturn. This market is currently valued at more than $42... |
Therapeutic Monoclonal Antibodies Markets
Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein... |
